MARKET

AORT

AORT

Artivion, Inc.
NYSE
25.06
-0.67
-2.60%
After Hours: 25.06 0 0.00% 19:10 07/17 EDT
OPEN
25.45
PREV CLOSE
25.73
HIGH
25.85
LOW
24.79
VOLUME
535.32K
TURNOVER
--
52 WEEK HIGH
48.25
52 WEEK LOW
19.16
MARKET CAP
1.22B
P/E (TTM)
104.81
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AORT last week (0706-0710)?
Weekly Report · 6d ago
Artivion (AORT) Is Up 10.1% After Full FDA PMA Approval for AMDS Aortic Device
Simply Wall St · 07/07 04:53
Weekly Report: what happened at AORT last week (0629-0703)?
Weekly Report · 07/06 10:05
Artivion (AORT) Wins FDA Approval, Is The Stock Still 53% Undervalued?
Simply Wall St · 07/05 18:26
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
NASDAQ · 07/02 14:09
2 Growth Stocks Set to Flourishand 1 We Ignore
Barchart · 07/02 02:42
Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion
Seeking Alpha · 06/30 13:30
Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target
TipRanks · 06/30 11:15
More
About AORT
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.